Is CLSD or SCHD a better dividend investment in 2026?

CLSD currently yields 487.80% with a 5% 5-year dividend growth rate. SCHD yields 3.46% with 13.05% growth. The better choice depends on your goal: CLSD offers higher current income.

What is the dividend yield difference between CLSD and SCHD?

CLSD has a forward dividend yield of 487.80% ($2.00/share annually). SCHD yields 3.46% ($1.06/share annually). The yield gap is 484.34 percentage points.

Home › Compare › CLSD vs SCHD

CLSD vs SCHD: Dividend Comparison 2026

CLSD yields 487.80% · SCHD yields 3.46%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CLSD wins by $50753.86M in total portfolio value

INVESTMENT

TIME HORIZON10 years

CLSD

● Live price

487.80%

Share price

$0.41

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$50753.89M

Annual income

$36,168,404,531.85

Full CLSD calculator →

SCHD

Schwab U.S. Dividend Equity ETF

● Live price

3.46%

Share price

$30.48

Annual div

$1.06

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29.0K

Annual income

$425.95

Full SCHD calculator →

Portfolio growth — CLSD vs SCHD

📍 CLSD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CLSD	SCHD
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CLSD + SCHD cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CLSD pays

SCHD pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CLSD

Annual income on $10K today (after 15% tax)

$41,463.41/yr

After 10yr DRIP, annual income (after tax)

$30,743,143,852.07/yr

SCHD

Annual income on $10K today (after 15% tax)

$294.40/yr

After 10yr DRIP, annual income (after tax)

$362.06/yr

At 15% tax rate, CLSD beats the other by $30,743,143,490.02/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CLSD + SCHD for your $10,000?

CLSD: 50%SCHD: 50%

100% SCHD50/50100% CLSD

Portfolio after 10yr

$25376.96M

Annual income

$18,084,202,478.90/yr

Blended yield

71.26%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on CLSD right now

CLSD

Analyst Ratings

Buy

Hold

Consensus: Buy

Altman Z

-48.3

Piotroski

2/9

SCHD

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CLSD buys

SCHD buys

Politician	Chamber	Ticker	Type	Amount	Date
Virginia Foxx	🏢 House	$SCHD	▼ Sell	$50,001 - $100,000	2023-03-08
Steve Cohen	🏢 House	$SCHD	▲ Buy	$50,001 - $100,000	2022-07-29
Hakeem S. Jeffries	🏢 House	$SCHD	▲ Buy	$15,001 - $50,000	2021-04-12
Mikie Sherrill	🏢 House	$SCHD	▲ Buy	$100,001 - $250,000	2020-02-21

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCLSDSCHD

Forward yield	487.80% ✓	3.46%
Annual dividend / share	$2.00 ✓	$1.06
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$50753.89M ✓	$29.0K
Annual income after 10y	$36,168,404,531.85 ✓	$425.95
Total dividends collected	$49478.61M ✓	$3.9K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: CLSD vs SCHD ($10,000, DRIP)

Year	CLSD Portfolio	CLSD Income/yr	SCHD Portfolio	SCHD Income/yr	Gap
1← crossover	$59,480	$48,780.49	$11,226	$346.36	+$48.3K → CLSD
2	$334,811	$271,167.03	$12,572	$357.38	+$322.2K → CLSD
3	$1,784,770	$1,426,522.08	$14,046	$367.84	+$1.77M → CLSD
4	$9,016,553	$7,106,848.63	$15,660	$377.73	+$9.00M → CLSD
5	$43,202,271	$33,554,559.81	$17,425	$387.07	+$43.18M → CLSD
6	$196,483,123	$150,256,693.49	$19,354	$395.86	+$196.46M → CLSD
7	$848,895,486	$638,658,543.63	$21,461	$404.13	+$848.87M → CLSD
8	$3,487,095,949	$2,578,777,778.75	$23,762	$411.89	+$3487.07M → CLSD
9	$13,631,297,985	$9,900,105,319.66	$26,272	$419.15	+$13631.27M → CLSD
10	$50,753,893,375	$36,168,404,531.85	$29,010	$425.95	+$50753.86M → CLSD

CLSD vs SCHD: Complete Analysis 2026

CLSD — Stock

Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injectable suspension for suprachoroidal injection, which is in Phase 1/2a clinical trial; and CLS-301, an integrin inhibitor suspension for the treatment of diabetic macular edema and macular degeneration. The company has a collaboration with Bausch Health, Arctic Vision, REGENXBIO, Inc., and Aura Biosciences. Clearside Biomedical, Inc. was incorporated in 2011 and is headquartered in Alpharetta, Georgia.

Full CLSD Calculator →

SCHD — ETF

The fund’s goal is to track as closely as possible, before fees and expenses, the total return of the Dow Jones U.S. Dividend 100 Index.

Full SCHD Calculator →

📬

Get this CLSD vs SCHD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CLSD vs JEPI CLSD vs O CLSD vs KO CLSD vs MAIN CLSD vs VYM CLSD vs DGRO CLSD vs VIG CLSD vs HDV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.